Navigation Links
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
Date:9/23/2009

SAN FRANCISCO, September 23 /PRNewswire/ -- InspireMD, developers of MGuard(TM), announced today that the first patient has been enrolled in the Israeli MGuard(TM) Registry. MGuard(TM) was successfully implanted in Natanya, Israel, at the Laniado Hospital Cath Lab, managed by Dr. Yitzhak Herz, the principal investigator for the Registry at this hospital.

The Israeli MGuard Registry will enroll 100 'real world' MGuard patients from eight hospitals in Israel. Data from the registry will be used to support data from other MGuard clinical studies.

The first MGuard Stent in the Israeli MGuard Registry was implanted by Dr. Guy Schoenmann from the Laniado Hospital in Netanya. The patient was a 70 year old male treated for myocardial infarction (MI) caused by a thrombus occluding the right coronary artery. Dr. Schoenmann stated: "MGuard(TM) was delivered with no complications and it immediately enabled excellent flow in the artery. We experienced a very successful procedure and I am very pleased that MGuard is now available to us on daily basis".

Mr. Eli Bar CTO and VP R&D stated: "Currently MGuard is mostly used in AMI, SVG, and thrombus containing lesions. The Israeli MGuard registry is very important for us in order to understand the clinical performance of MGuard in the 'real world' and receive a wider perspective on its use in special patient subgroups".

On September 24th 2009, InspireMD will Sponsor a Breakfast Meeting at the TCT Conference 2009 in San Francisco, Titled "The Role of the MGuard(TM) Stent in Thrombus Management During AMI Interventions". The meeting chairman will be Dr. Martin B. Leon , the Chairman of the CRF, NY; Associate Director at New York Presbyterian Hospital and Professor at Columbia University Medical Center NY. InspireMD's Breakfast Meeting faculty will include Alexandre Abizaid, MD, PhD, Antonio Colombo, MD, Peter J. Fitzgerald, MD, PhD,
'/>"/>

SOURCE InspireMD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
2. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
3. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
4. MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
5. XRC Medical Imaging Announces Rapid Test Results
6. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
7. Boston Scientific Announces Release of Next-Generation iLab(R) System Software
8. Brennen Medical Announces Sale of XenMatrix(R)
9. PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone
10. AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS-112 in Cancer
11. Halocarbon Announces Licensing Agreement with IBM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Hospital Energy Performance Service can help ... energy efficiency by 25% or more ... The service is available from Environmental Health ... and engineering consulting firm."Healthcare facilities are heavy energy users and ...
... Inc., a privately-held specialty pharmaceutical company, announced today that ... evaluate EVK-001 for the treatment of adults with symptoms ... delayed emptying of the stomach into the intestine following ... is an important cause of gastroparesis, but other identified ...
... Mass., May 5 Syrinx Consulting Corporation ... that delivers easy-to-use .Net and SharePoint applications ... contract for approximately $100,000 with a leading biopharmaceutical company ... migrating thousands of users and gigabytes of data from ...
Cached Biology Technology:New Hospital Energy Performance Service Helps Hospitals Cut Energy Costs by 25% or More 2Evoke Pharma, Inc. Initiates Phase 2b Metoclopramide Intranasal Trial (MINT) in Patients With Diabetic Gastroparesis 2Evoke Pharma, Inc. Initiates Phase 2b Metoclopramide Intranasal Trial (MINT) in Patients With Diabetic Gastroparesis 3Syrinx Wins Contract with Leading Pharmaceutical Company for SharePoint 2007 Services 2
(Date:4/15/2014)... American Association of Anatomists (AAA) is honored to announce ... presented during the Closing Awards Ceremony being held at ... at 7:30 p.m. during AAA,s 2014 Annual Meeting at ... winners are: , Henry Gray/Elsevier Distinguished Educator ... of Medicine at Mount Sinai, Past-President of the American ...
(Date:4/15/2014)... In recent years, it has become clear that ... previously assumed. In addition to the well-known building ... variations play an important role. Scientists now assume ... form a second layer of information that extends ... are rather like umlauts that extend the standard ...
(Date:4/14/2014)... subarctic forest moths in Finnish Lapland suggests that scientists ... animals and plants because much of the harm is ... 80 moth species and found that 90 percent of ... period, from 1978 to 2009. During that time, average ... Fahrenheit, and winter precipitation increased as well. , "You ...
Breaking Biology News(10 mins):American Association of Anatomists 2014 award winners 2German Research Foundation approves new priority program in the life sciences 2Moth study suggests hidden climate change impacts 2Moth study suggests hidden climate change impacts 3
... They may never win an Oscar, but scientists at ... have developed techniques for creating accurate movies of biological ... now. Biological and organic molecules in solution ... of salt or metals since they are constantly moving ...
... increased risk of wheezing in the chest if they take part ... shown in a new study using data from the Norwegian Mother ... (NIPH). The results come from a study of ... children took part in baby swimming from 0-6 months of age. ...
... is available in French . , ... Management, the private bankers Lombard Odier Darier Hentsch & ... at EPFL dedicated to sustainable development. The chair is ... fundamental and social sciences in the environmental domain. ...
Cached Biology News:Argonne scientists develop techniques for creating molecular movies 2Possible link between baby swimming and breathing problems in children 2EPFL Research Day 2008, in the presence of Al Gore 2EPFL Research Day 2008, in the presence of Al Gore 3
... strains are K-12 derivatives that have mutations ... glutathione reductase (gor) genes, which greatly enhances ... have shown that expression in Origami(DE3) yielded ... host even though overall expression levels were ...
Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
... Cy3 Ab Labeling Kit, 1 kit. ... CyDye fluorescent dyes. Conjugations are carried ... within 1 h. Dyes are packaged ... ensure consistent labelings. Category: Blotting & ...
Recombinant Human Erythropoietin (Tissue Culture Grade)...
Biology Products: